Saudi Kayan Petrochemical Company (TADAWUL:2350)

CTI BioPharma Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,335	10,530	16,440	20,490	25,530	21,450
Market Cap Growth	-35.94%	-35.95%	-19.77%	-19.74%	19.02%	28.83%
Enterprise Value	16,111	19,433	26,268	30,797	39,088	37,514
Last Close Price	4.89	7.02	10.96	13.66	17.02	14.30
PE Ratio	-	-	-	-	10.68	-
Forward PE	-	-	-	60.79	17.29	-
PS Ratio	0.82	1.21	2.01	1.84	2.02	2.68
PB Ratio	0.72	0.92	1.24	1.32	1.55	1.53
P/TBV Ratio	0.73	0.93	1.26	1.34	1.57	1.56
P/FCF Ratio	49.44	7.42	158.90	7.25	7.50	11.67
P/OCF Ratio	10.62	4.99	18.59	6.44	6.67	9.82
PEG Ratio	-	0.28	0.28	0.28	0.28	0.28
EV/Sales Ratio	1.80	2.23	3.22	2.76	3.09	4.68
EV/EBITDA Ratio	29.14	18.89	26.06	20.69	7.61	17.74
EV/EBIT Ratio	-	-	-	-	14.01	-
EV/FCF Ratio	108.59	13.68	253.90	10.90	11.48	20.41
Debt / Equity Ratio	0.92	0.73	0.77	0.65	0.81	1.22
Debt / EBITDA Ratio	16.98	7.85	9.66	6.55	2.58	7.84
Debt / FCF Ratio	63.27	5.90	98.30	3.56	3.93	9.27
Asset Turnover	0.36	0.34	0.30	0.37	0.38	0.23
Inventory Turnover	7.18	7.22	6.85	7.17	5.94	5.77
Quick Ratio	0.59	0.37	0.47	0.64	1.24	1.18
Current Ratio	0.94	0.59	0.72	1.03	1.74	1.65
Return on Equity (ROE)	-19.81%	-14.55%	-14.86%	-7.79%	15.69%	-5.42%
Return on Assets (ROA)	-4.63%	-3.34%	-3.19%	-1.75%	5.25%	-0.34%
Return on Capital (ROIC)	-5.55%	-3.97%	-3.57%	-1.93%	5.73%	-0.37%
Return on Capital Employed (ROCE)	-	-	-	-	9.70%	-
Earnings Yield	-30.73%	-17.13%	-13.00%	-6.07%	9.36%	-3.66%
FCF Yield	2.02%	13.49%	0.63%	13.79%	13.34%	8.57%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.